Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
36 /100
MEDIUM RISK
Score updated Aug 28, 2026

RGNT — Regentis Biomaterials Ltd. Dilution Risk Tracker

Track RGNT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RGNT — Get alerts when the score changes →

As of August 28, 2026, Regentis Biomaterials Ltd. (RGNT) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. Regentis Biomaterials Ltd. has a market capitalization of $9.58M, 5.18M shares outstanding, 3 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
42
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for RGNT.
🔔 Track RGNT — Get forecast alerts →

Market Data

Market Cap$9.58M
Shares Outstanding5.18M
Float2.82M
Cash$7.38M
Debt$1.20M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 96.4% shares (2026Q1 vs prior)
3 institutional holders · 551.8K shares
#1 AIGH Capital Management LLC 300.0K shares
#2 Rosalind Advisors, Inc. 251.5K shares
#3 UBS Group AG 334 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest37.1K
Days to Cover1.0
% of Float1.3%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2025-12-31
3 FORM3 2026-03-30
3 FORM3 2026-03-18
3 FORM3 2026-03-18
Full SEC filing analysis available with free account

Recent News

No recent news

Factual RGNT Dilution Snapshot

Regentis Biomaterials Ltd. (RGNT) has a DilutionScore of 36/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track RGNT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RGNT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for RGNT
RGNT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.